Bora Pharmaceuticals Dividends and Buybacks
Dividend criteria checks 3/6
Bora Pharmaceuticals is a dividend paying company with a current yield of 1.8% that is well covered by earnings.
Key information
1.8%
Dividend yield
0.4%
Buyback Yield
| Total Shareholder Yield | 2.2% |
| Future Dividend Yield | 1.8% |
| Dividend Growth | 39.1% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | NT$14.000 |
| Payout ratio | 36% |
Recent dividend and buyback updates
Recent updates
We Think Bora Pharmaceuticals (TWSE:6472) Can Stay On Top Of Its Debt
Jan 20
Bora Pharmaceuticals' (TWSE:6472) Earnings Are Weaker Than They Seem
Nov 21Does Bora Pharmaceuticals (TWSE:6472) Deserve A Spot On Your Watchlist?
Oct 04Investors Appear Satisfied With Bora Pharmaceuticals Co., LTD.'s (TWSE:6472) Prospects
Jul 18Is Bora Pharmaceuticals Co., LTD. (TWSE:6472) Trading At A 44% Discount?
Jun 13Bora Pharmaceuticals Co., LTD. (TWSE:6472) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected
Apr 10Bora Pharmaceuticals (TWSE:6472) Could Easily Take On More Debt
Apr 08Shareholders Can Be Confident That Bora Pharmaceuticals' (TWSE:6472) Earnings Are High Quality
Mar 14Is Bora Pharmaceuticals (GTSM:6472) A Risky Investment?
Apr 30Are Strong Financial Prospects The Force That Is Driving The Momentum In Bora Pharmaceuticals Co., LTD.'s GTSM:6472) Stock?
Mar 17Bora Pharmaceuticals (GTSM:6472) Has Rewarded Shareholders With An Exceptional 695% Total Return On Their Investment
Feb 17
New Forecasts: Here's What Analysts Think The Future Holds For Bora Pharmaceuticals Co., LTD. (GTSM:6472)
Jan 27Bora Pharmaceuticals (GTSM:6472) Takes On Some Risk With Its Use Of Debt
Jan 19We're Not So Sure You Should Rely on Bora Pharmaceuticals's (GTSM:6472) Statutory Earnings
Dec 29Are Robust Financials Driving The Recent Rally In Bora Pharmaceuticals Co., LTD.'s (GTSM:6472) Stock?
Dec 09Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 6472's dividend payments have been volatile in the past 10 years.
Growing Dividend: 6472's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Bora Pharmaceuticals Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (6472) | 1.8% |
| Market Bottom 25% (TW) | 1.8% |
| Market Top 25% (TW) | 4.5% |
| Industry Average (Pharmaceuticals) | 2.3% |
| Analyst forecast (6472) (up to 3 years) | 1.8% |
Notable Dividend: 6472's dividend (1.8%) is higher than the bottom 25% of dividend payers in the TW market (1.76%).
High Dividend: 6472's dividend (1.8%) is low compared to the top 25% of dividend payers in the TW market (4.49%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (36.2%), 6472's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (492.6%), 6472's dividend payments are not well covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/03/14 01:57 |
| End of Day Share Price | 2025/03/14 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Bora Pharmaceuticals Co., LTD. is covered by 7 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jianzheng Wu | Capital Securities Corporation |
| Hsuan Chen | KGI Securities Co. Ltd. |
| null null | KGI Securities Co. Ltd. |